These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24429012)

  • 81. Interaction between fenofibrate and warfarin.
    Ascah KJ; Rock GA; Wells PS
    Ann Pharmacother; 1998; 32(7-8):765-8. PubMed ID: 9681093
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Warfarin and celecoxib interaction.
    Mersfelder TL; Stewart LR
    Ann Pharmacother; 2000 Mar; 34(3):325-7. PubMed ID: 10917378
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
    Howard-Thompson A; Hurdle AC; Arnold LB; Finch CK; Sands C; Self TH
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):33-6. PubMed ID: 18396247
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy.
    Le AT; Hasson NK; Lum BL
    Ann Pharmacother; 1997 Sep; 31(9):1006-8. PubMed ID: 9296241
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A review of warfarin dosing with concurrent acetaminophen therapy.
    Pinson GM; Beall JW; Kyle JA
    J Pharm Pract; 2013 Oct; 26(5):518-21. PubMed ID: 23736105
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Patient Satisfaction With Extended International Normalized Ratio Follow-up Intervals in a Veteran Population.
    Schoen RR; Nagy MW; Porter AL; Margolis AR
    Ann Pharmacother; 2020 May; 54(5):442-449. PubMed ID: 31752504
    [No Abstract]   [Full Text] [Related]  

  • 88. Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR.
    Brown GW; Bellnier TJ; Janda M; Miskowitz K
    J Am Pharm Assoc (2003); 2021; 61(1):e57-e60. PubMed ID: 32828704
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of gefitinib on warfarin antithrombotic activity.
    Arai S; Mitsufuji H; Nishii Y; Onoda S; Ryuge S; Wada M; Katono K; Iwasaki M; Takakura A; Otani S; Yamamoto M; Yanaihara T; Yokoba M; Kubota M; Katagiri M; Fukui T; Kobayashi H; Yanase N; Hataishi R; Masuda N
    Int J Clin Oncol; 2009 Aug; 14(4):332-6. PubMed ID: 19705244
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area.
    Njovane XW; Fasinu PS; Rosenkranz B
    Cardiovasc J Afr; 2013 Mar; 24(2):19-23. PubMed ID: 23750346
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature.
    Martins MA; Reis AM; Sales MF; Nobre V; Ribeiro DD; Rocha MO; Ribeiro AL
    BMC Pharmacol Toxicol; 2013 May; 14():27. PubMed ID: 23641931
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
    Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Warfarin Patients With Anemia Show Trend of Out-of-Range International Normalized Ratio Frequency With Point-of-Care Testing in an Anticoagulation Clinic.
    DeRemer CE; McMichael B; Young HN
    J Pharm Pract; 2019 Oct; 32(5):499-502. PubMed ID: 29642733
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Postanalytical external quality assessment of warfarin monitoring in primary healthcare.
    Kristoffersen AH; Thue G; Sandberg S
    Clin Chem; 2006 Oct; 52(10):1871-8. PubMed ID: 16916987
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Probable Interaction Between Warfarin and Divalproex Sodium.
    Anderson SL; Marrs JC
    J Pharm Technol; 2014 Feb; 30(1):8-12. PubMed ID: 34860893
    [No Abstract]   [Full Text] [Related]  

  • 96. Effect of Quinolones Versus Cefixime on International Normalized Ratio Levels After Valve Replacement Surgery with Warfarin Therapy.
    Liaqat A; Khan AU; Asad M; Khalil AH
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31561580
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Warfarin dose adjustment required after cannabidiol initiation and titration.
    Cortopassi J
    Am J Health Syst Pharm; 2020 Oct; 77(22):1846-1851. PubMed ID: 33016308
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Failure mode and effects analysis to reduce risk of anticoagulation levels above the target range during concurrent antimicrobial therapy.
    Daniels LM; Barreto JN; Kuth JC; Anderson JR; Zhang B; Majka AJ; Morgenthaler TI; Tosh PK
    Am J Health Syst Pharm; 2015 Jul; 72(14):1195-203. PubMed ID: 26150569
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.
    Mannheimer B; Andersson ML; Järnbert-Pettersson H; Lindh JD
    J Thromb Haemost; 2016 Apr; 14(4):765-71. PubMed ID: 26792124
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy.
    Yamreudeewong W; Lower DL; Kilpatrick DM; Enlow AM; Burrows MM; Greenwood MC
    Pharmacotherapy; 2003 Mar; 23(3):333-8. PubMed ID: 12627932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.